×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
European Medicines Agency | - Sutent€¦ · BCRP. In study A6181038 the co administration of gefitinib, a BCRP inhibitor, did not result in a clinically relevant effect on the Cmax
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form